274 related articles for article (PubMed ID: 19293793)
1. An investigation of WNT pathway activation and association with survival in central nervous system primitive neuroectodermal tumours (CNS PNET).
Rogers HA; Miller S; Lowe J; Brundler MA; Coyle B; Grundy RG
Br J Cancer; 2009 Apr; 100(8):1292-302. PubMed ID: 19293793
[TBL] [Abstract][Full Text] [Related]
2. The role of the WNT/β-catenin pathway in central nervous system primitive neuroectodermal tumours (CNS PNETs).
Rogers HA; Ward JH; Miller S; Lowe J; Coyle B; Grundy RG
Br J Cancer; 2013 May; 108(10):2130-41. PubMed ID: 23591193
[TBL] [Abstract][Full Text] [Related]
3. Somatic mutations of WNT/wingless signaling pathway components in primitive neuroectodermal tumors.
Koch A; Waha A; Tonn JC; Sörensen N; Berthold F; Wolter M; Reifenberger J; Hartmann W; Friedl W; Reifenberger G; Wiestler OD; Pietsch T
Int J Cancer; 2001 Aug; 93(3):445-9. PubMed ID: 11433413
[TBL] [Abstract][Full Text] [Related]
4. CTNNB1, AXIN1 and APC expression analysis of different medulloblastoma variants.
Silva Rd; Marie SK; Uno M; Matushita H; Wakamatsu A; Rosemberg S; Oba-Shinjo SM
Clinics (Sao Paulo); 2013; 68(2):167-72. PubMed ID: 23525311
[TBL] [Abstract][Full Text] [Related]
5. Molecular stratification of medulloblastoma: comparison of histological and genetic methods to detect Wnt activated tumours.
Goschzik T; Zur Mühlen A; Kristiansen G; Haberler C; Stefanits H; Friedrich C; von Hoff K; Rutkowski S; Pfister SM; Pietsch T
Neuropathol Appl Neurobiol; 2015 Feb; 41(2):135-44. PubMed ID: 24894640
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of SOX2, NOTCH1, and ID1 in supratentorial primitive neuroectodermal tumors: a distinct differentiation pattern from that of medulloblastomas.
Phi JH; Kim JH; Eun KM; Wang KC; Park KH; Choi SA; Kim YY; Park SH; Cho BK; Kim SK
J Neurosurg Pediatr; 2010 Jun; 5(6):608-14. PubMed ID: 20515335
[TBL] [Abstract][Full Text] [Related]
7. Gene amplification in PNETs/medulloblastomas: mapping of a novel amplified gene within the MYCN amplicon.
Frühwald MC; O'Dorisio MS; Rush LJ; Reiter JL; Smiraglia DJ; Wenger G; Costello JF; White PS; Krahe R; Brodeur GM; Plass C
J Med Genet; 2000 Jul; 37(7):501-9. PubMed ID: 10882752
[TBL] [Abstract][Full Text] [Related]
8. Nuclear localization and mutation of beta-catenin in medulloblastomas.
Eberhart CG; Tihan T; Burger PC
J Neuropathol Exp Neurol; 2000 Apr; 59(4):333-7. PubMed ID: 10759189
[TBL] [Abstract][Full Text] [Related]
9. beta-Catenin status predicts a favorable outcome in childhood medulloblastoma: the United Kingdom Children's Cancer Study Group Brain Tumour Committee.
Ellison DW; Onilude OE; Lindsey JC; Lusher ME; Weston CL; Taylor RE; Pearson AD; Clifford SC;
J Clin Oncol; 2005 Nov; 23(31):7951-7. PubMed ID: 16258095
[TBL] [Abstract][Full Text] [Related]
10. Beta-catenin status in paediatric medulloblastomas: correlation of immunohistochemical expression with mutational status, genetic profiles, and clinical characteristics.
Fattet S; Haberler C; Legoix P; Varlet P; Lellouch-Tubiana A; Lair S; Manie E; Raquin MA; Bours D; Carpentier S; Barillot E; Grill J; Doz F; Puget S; Janoueix-Lerosey I; Delattre O
J Pathol; 2009 May; 218(1):86-94. PubMed ID: 19197950
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of chromosome 17p deletions in childhood primitive neuroectodermal tumors (medulloblastomas) of the central nervous system.
Biegel JA; Janss AJ; Raffel C; Sutton L; Rorke LB; Harper JM; Phillips PC
Clin Cancer Res; 1997 Mar; 3(3):473-8. PubMed ID: 9815707
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of somatostatin receptors, P44/42 MAPK, and mTOR activation in medulloblastomas and primitive neuroectodermal tumors.
Johnson MD; O'Connell MJ; Silberstein H; Korones D
Appl Immunohistochem Mol Morphol; 2013 Dec; 21(6):532-8. PubMed ID: 23455179
[TBL] [Abstract][Full Text] [Related]
13. Supratentorial CNS-PNETs in children; a Swedish population-based study with molecular re-evaluation and long-term follow-up.
Schepke E; Löfgren M; Pietsch T; Kling T; Nordborg C; Olsson Bontell T; Holm S; Öberg A; Nyman P; Eliasson-Hofvander M; Sabel M; Lannering B; Carén H
Clin Epigenetics; 2023 Mar; 15(1):40. PubMed ID: 36895035
[TBL] [Abstract][Full Text] [Related]
14. Genome-wide molecular characterization of central nervous system primitive neuroectodermal tumor and pineoblastoma.
Miller S; Rogers HA; Lyon P; Rand V; Adamowicz-Brice M; Clifford SC; Hayden JT; Dyer S; Pfister S; Korshunov A; Brundler MA; Lowe J; Coyle B; Grundy RG
Neuro Oncol; 2011 Aug; 13(8):866-79. PubMed ID: 21798848
[TBL] [Abstract][Full Text] [Related]
15. Mutations in the human homologue of the Drosophila segment polarity gene patched (PTCH) in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system.
Wolter M; Reifenberger J; Sommer C; Ruzicka T; Reifenberger G
Cancer Res; 1997 Jul; 57(13):2581-5. PubMed ID: 9205058
[TBL] [Abstract][Full Text] [Related]
16. Prolongation of radiotherapy duration is associated with inferior overall survival in patients with pediatric medulloblastoma and central nervous system primitive neuroectodermal tumors.
Baliga S; Bajaj BVM; Kabarriti R; Grassberger C; Patteson B; Yeap B; Fox JL; Garg MK; Yock TI
Pediatr Blood Cancer; 2020 Oct; 67(10):e28558. PubMed ID: 32710698
[TBL] [Abstract][Full Text] [Related]
17. H3.3 G34R mutations in pediatric primitive neuroectodermal tumors of central nervous system (CNS-PNET) and pediatric glioblastomas: possible diagnostic and therapeutic implications?
Gessi M; Gielen GH; Hammes J; Dörner E; Mühlen AZ; Waha A; Pietsch T
J Neurooncol; 2013 Mar; 112(1):67-72. PubMed ID: 23354654
[TBL] [Abstract][Full Text] [Related]
18. Atypical teratoid/rhabdoid tumor of the central nervous system: a comparative study with primitive neuroectodermal tumor/medulloblastoma.
Ho DM; Hsu CY; Wong TT; Ting LT; Chiang H
Acta Neuropathol; 2000 May; 99(5):482-8. PubMed ID: 10805090
[TBL] [Abstract][Full Text] [Related]
19.
Beckmann PJ; Larson JD; Larsson AT; Ostergaard JP; Wagner S; Rahrmann EP; Shamsan GA; Otto GM; Williams RL; Wang J; Lee C; Tschida BR; Das P; Dubuc AM; Moriarity BS; Picard D; Wu X; Rodriguez FJ; Rosemarie Q; Krebs RD; Molan AM; Demer AM; Frees MM; Rizzardi AE; Schmechel SC; Eberhart CG; Jenkins RB; Wechsler-Reya RJ; Odde DJ; Huang A; Taylor MD; Sarver AL; Largaespada DA
Cancer Res; 2019 Mar; 79(5):905-917. PubMed ID: 30674530
[TBL] [Abstract][Full Text] [Related]
20. Wnt/beta-catenin pathway deregulation in childhood adrenocortical tumors.
Leal LF; Mermejo LM; Ramalho LZ; Martinelli CE; Yunes JA; Seidinger AL; Mastellaro MJ; Cardinalli IA; Brandalise SR; Moreira AC; Tone LG; Scrideli CA; Castro M; Antonini SR
J Clin Endocrinol Metab; 2011 Oct; 96(10):3106-14. PubMed ID: 21849527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
